Skip to main content
logo
ENvue Medical, Inc. (FEED)
OTCMKTS · Delayed Price · Currency is USD
1.030
-2.320 (-69.25%)
At close: Sep 15, 2026

ENvue Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.932.552.562.280.751.7
Revenue Growth
-17.66%-0.19%12.05%203.59%-55.63%172.07%
Gross Profit
-0.50.151.511.540.170.77
Operating Income
-15.09-11.74-3.58-3.08-5.01-4.18
Net Income
-49.19-16.78-3.71-3.71-5.45-14.28
Earnings Per Share
-206.88-320.27----
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Nano Vibronix
1.081.862.56
Envue
0.850.7-
Total
1.932.552.56

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.084.220.753.282.717.74
Total Debt
1.311.20.120.010.080.05
Net Cash (Debt)
-0.233.030.643.282.637.69
Net Cash Growth
-375.94%-80.60%24.54%-65.77%8.11%
Net Cash Per Share
-0.9557.79----

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.65-9.37-2.52-3.6-7.04-4.37
Capital Expenditures
-0.1-0.06-0-0-0-0
Free Cash Flow
-11.74-9.43-2.52-3.6-7.04-4.37
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-26.06%5.99%58.95%67.32%22.21%45.43%
Operating Margin
-783.59%-459.65%-140.03%-134.74%-666.49%-246.78%
Pretax Margin
-1111.94%-724.32%-144.10%-161.28%-719.81%-840.71%
Profit Margin
-2553.89%-657.07%-144.84%-162.55%-724.47%-842.60%
FCF Margin
-609.76%-369.45%-98.47%-157.82%-935.90%-257.82%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.490.990.871.0310.992495.47